Joint Action5 Jan 2025

The key to better osteoarthritis treatments: clinical trials explained with Dr Karen Bracken

Welcome to Season 6 of the Joint Action Podcast and the first episode of 2025! We're kicking off with a crucial topic in advancing osteoarthritis treatment: understanding clinical trials.

Clinical trials are vital for developing new treatments for osteoarthritis, yet many people are mystified by the process. Why participate? What are the benefits? What are the risks? In this episode, we break it all down with Dr. Karen Bracken, Clinical Trial Program Lead at the Kolling Institute, University of Sydney. With over 20 years of experience managing clinical trials, Karen provides an insider’s perspective on the motivations, processes, and considerations involved in clinical research.

Join us as we explore:

The potential benefits of participating in clinical trials, such as access to new treatments and contributing to science.
Key considerations, including time commitments and informed consent.
How clinical trials are designed to prioritise participant safety and generate reliable evidence.
Misconceptions about clinical trials and how they differ from reality.

We also discuss exciting ongoing trials, including the ATLAS study for knee osteoarthritis, the TOPS osteoarthritis prevention study, and the MARVEL study exploring the impact of pentosan polysulfate sodium on knee pain.

Whether you're curious about clinical trials or considering participating in one, this episode offers valuable insights to guide your journey.

RESOURCES

To learn more about osteoarthritis clinical trials, visit our website: www.osteoarthritisresearch.com.au

To learn more about the Osteoarthritis Research Participant Network or to join, click here: www.osteoarthritisresearch.com.au/oa-participant-network

Current osteoarthritis studies:

The ATLAS study: www.osteoarthritisresearch.com.au/atlas-study-overview
TOPS study: www.osteoarthritisresearch.com.au/tops-study-overview
The MaRVeL study: www.osteoarthritisresearch.com.au/marvel-study-overview

Previous podcast episodes

S05E05 - Core outcome sets for osteoarthritis trials with Prof. Toby Smith

Websites

OMERACT - Outcome Measures in Rheumatology: www.omeract.org

Hosted on Acast. See acast.com/privacy for more information.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(175)

Your osteoarthritis listener questions with Vicky and David

Have you ever wondered whether your painful, stiff joints are just something you have to put up with, or whether there is actually something that can be done? On this week's episode of Joint Action, V...

19 Juli 28min

Choosing shoes for osteoarthritis with A/Prof Kade Paterson

Could the shoes you wear every day be making your knee osteoarthritis better or worse? On this week's episode of Joint Action, Kade Paterson joins Professor David Hunter to explain why footwear matter...

5 Juli 33min

Science without borders: a call to the osteoarthritis community

What happens to global science when funding is cut, borders close, and collaboration is threatened? In this special episode of Joint Action, Professor David Hunter reflects on the proposed changes to ...

21 Juni 17min

When we say “the evidence shows this works,” who was actually included in that evidence? with Prof Christian Barton

When we say a treatment works for knee osteoarthritis, it is worth asking: works for whom? On this week's episode of Joint Action, Professor Christian Barton unpacks the blind spots in osteoarthritis ...

7 Juni 30min

Your osteoarthritis listener questions with David and Vicky

This week on Joint Action, Vicky turns the tables and puts the questions to Professor David Hunter. Three listeners submitted questions spanning gut health, total knee replacement, and the frustrating...

24 Maj 22min

Do you really need surgery for your knee osteoarthritis? with Dr Howard Luks (2021)

The number of surgical procedures for musculoskeletal diseases such as osteoarthritis has increased exponentially over the past years, some of which are unnecessary and leave patients no better off th...

10 Maj 41min

Finding Responders: The Next Phase of OA Biomarkers with Dr Virginia Kraus, Dr Peter Mesenbrink, and Dr Jamie Collins

Can identifying the right patients and the right endpoints transform how we test new osteoarthritis treatments? On this week's episode of Joint Action, we unpack what the FNIH Biomarkers Consortium ha...

26 Apr 29min

Defining the early-stage OA patient: the EsSKOA initiative with Dr Armaghan Mahmoudian

What does it actually mean to have 'early-stage' osteoarthritis, and does catching it sooner really make a difference? On this week's episode of Joint Action, learn more about early-stage knee osteoar...

12 Apr 38min